Engineering T-cells with chimeric antigen receptors to combat hematological cancers: an update on clinical trials

Date Published

October 6, 2022

Ormhoj M, Abken H, Hadrup SR. Engineering T-cells with chimeric antigen receptors to combat hematological cancers: an update on clinical trials. Cancer Immunol Immunother. 2022 Oct. 71:2301-2311. doi:10.1007/s00262-022-03163-y. PMID: 35199207